Evidence in vivo for induction of cardiovascular growth processes by vasoconstrictor systems.
Greater smooth muscle growth is an important feature of the changes in blood vessel morphology in hypertension. The increase in vessel wall thickness: lumen ratio resulting from vascular hypertrophy impacts directly on total peripheral vascular resistance thereby influencing the severity of hypertension. The roles played by mechanical forces, vasoactive substances, growth factors and endocrine hormones in mediating hypertrophic vascular growth responses in vivo are currently under investigation. Here we review our current research aimed at: (a) defining the roles in vivo, of the renin-angiotensin system (RAS) and sympathetic nervous system (SNS), in the development of cardiovascular hypertrophy; (b) defining the importance of endogenous vasodilator systems, in particular, the ability of nitric oxide to inhibit trophic responses induced by the RAS and SNS and (c) examining whether trophic stimulation via the two neurohumoral systems as well as the antitrophic activity of the vasodilator systems is in part dependent on changes in blood pressure. In these studies the obligatory enzyme ornithine decarboxylase has proved to be a useful marker of ongoing hypertrophic cardiovascular growth.
Adams
M A
MA
Department of Pharmacology and Toxicology, Queen's University, Kingston, Canada.
Thompson
K E
KE
Banting
J D
JD
Madigan
M A
MA
Friberg
P
P
D000818:Animals; D001808:Blood Vessels / Q000473:pathology*; D006332:Cardiomegaly / Q000209:etiology* / Q000503:physiopathology; D006973:Hypertension / Q000209:etiology / Q000503:physiopathology*; D006984:Hypertrophy; D014661:Vasoconstriction / Q000502:physiology*